Top-News
Verkauf, spezialisiert Schweden

Cellavision News

Aktie
WKN:  A0NEVD ISIN:  SE0000683484 US-Symbol:  CLVSF
20,75 €
+0,05 €
+0,24%
08:11:59 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
23,85 Mio.
Marktkapitalisierung *
476,05 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 19.04.2023

Cellavision News

16.07.20 - GlobeNewswire
CellaVision AB: Good profitability despite negative COVID-19-effect
The information was submitted for publication at 08.20 CET on July 16, 2020
07.07.20 - GlobeNewswire
CellaVision AB presents the second quarter for 2020
CellaVision presents the second quarter for 2020 on July 16, at 11:00 CET
29.05.20 - GlobeNewswire
CellaVision AB: Zlatko Rihter leaves his position as CEO at CellaVision AB
The information was released for public disclosure on May 29, 2020, at 08:20 CET
26.05.20 - GlobeNewswire
CellaVision AB: CellaVisions Annual report for 2019 is now available
The information was released for public disclosure on May 26, 2020, at 08:20 CET
13.05.20 - GlobeNewswire
CellaVision AB: Notice of the Annual General Meeting 2020
The information was submitted to the public on May 13, 2020 at 8:20 CET
22.04.20 - GlobeNewswire
CellaVision AB: Stable start of the year with good growth in APAC
The information was submitted for publication at 08.20 CET on April 22, 2020
15.04.20 - GlobeNewswire
CellaVision AB presents the first quarter for 2020 on April 22, at 11:00 CET
The information was submitted to the public on April 15, 2020 at 8:20 CET
26.03.20 - GlobeNewswire
CellaVision AB: The Annual General Meeting of CellaVision AB (publ) is postponed and the Board of Directors has decided to withdraw the proposed dividend due to the coronavirus, Covid-19
The information was submitted for publication March 26, 2020, at. 8.20 (CET)
20.03.20 - GlobeNewswire
CellaVision AB: Notice of 2020 Annual General Meeting of CellaVision (publ)
The information was submitted to the public on March 20, 2020 at 8:20 CET
05.02.20 - GlobeNewswire
CellaVision AB: Nomination Committee proposes re-election of Chairman and members to the Board of Directors
The information was submitted to the public on February 5, 2020 at 8:25 CET
05.02.20 - GlobeNewswire
CellaVision AB: Year-end bulletin, Jan-Dec 2019
Stable quarter including earnings from RAL Diagnostics
24.01.20 - GlobeNewswire
CellaVision AB presents the year-end bulletin for 2019 on February 5 at 11:00 CET
The information was submitted to the public on January 24, 2020 at 8:20 CET
23.10.19 - GlobeNewswire
CellaVision AB: Continued growth and acquisition of RAL Diagnostics
10.10.19 - GlobeNewswire
CellaVision AB presents the third quarter for 2019 on October 23 at 11:00 CET
The information was submitted to the public on October 10, 2019 at 8:20 CET
02.10.19 - GlobeNewswire
CellaVision completes the acquisition of RAL Diagnostics
The information was released for public disclosure on October 2, 2019, at 14:30 CET
16.09.19 - GlobeNewswire
CellaVision invites to a telephone and audio webcast on September 17, at 11:00 CET to present the signing of an agreement to acquire the French company RAL Diagnostics
The information was submitted to the public on September 16, 2019 at 18:45 CET
16.09.19 - GlobeNewswire
CellaVision AB to acquire RAL Diagnostics
A unique combination of high-​quality sample preparation and world-​leading digital cell morphology.
16.07.19 - GlobeNewswire
CellaVision ABs strongest quarter ever with continued growth
The information was submitted for publication at 08.20 CET on July 16, 2019
02.07.19 - GlobeNewswire
CellaVision AB presents the second quarter for 2019 on July 16 at 11:00 CET
The information was submitted to the public on July 2, 2019 at 8:20 CET
08.05.19 - GlobeNewswire
CellaVision AB: Bulletin from AGM held on May 8, 2019
Annual General Meeting of CellaVision AB (publ) on May 8, 2019 The information was submitted to the public on May 8, 2019 at 20:30 CellaVision AB (publ) held the Annual General ...

Newssuche

Videos

newspaper
17.05.24 -6,64%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »